Clinical Trial Update: Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease [NA]

View source ↗

Summary

A clinical study is evaluating BRL-101 for treating sickle cell disease, assessing safety and efficacy, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• BRL-101

Snippet

Sponsor: Bioray Laboratories | Conditions: Sickle Cell Disease | NA | Status: NOT_YET_RECRUITING